non-Hodgkin\'s
Pediatric Non Hodgkin’s Lymphomas
... Burkitt NHL is characterised by a short cell cy- cle, a high proliferation rate, large tumours, an early dissemination especially in CNS, and early re- lapses within one year after diagnosis. So, general principles of ...
6
Fertility preservation with successful pregnancy outcome in a patient with transplanted heart and non Hodgkin’s lymphoma – a case report
... On the other hand, fertility and pregnancy in heart transplant patients raise complex issues, considering the high risk for potential maternal and foetal complications [3]. Since the first successful pregnancy after ...
5
Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib
... drug targeting the proteolytic core subunit of the 26S proteasome, has emerged as a therapeutic alternative in follicular lymphoma, with promising preclinical data and efficacy in patients with other hematological ...
13
An atypical presentation of sporadic ovarian Burkitt’s lymphoma: case report and review of the literature
... 7. Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH: Primary ovarian non-Hodgkin ’ s lymphoma: outcome after treatment with combination chemotherapy. Gynecol Oncol 1997, 64:446 ...
5
Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study
... We used record-linkage analysis to evaluate AIDS-defining cancers in Nigeria and provide insights about their risk. Consistent with the findings from other studies, the risk of Kaposi Sarcoma but not Cervical Cancer or ...
7
Single nucleotide polymorphisms of microRNA processing genes and outcome of non-Hodgkin’s lymphoma
... Objective: microRNA (miRNA)-related single nucleotide polymorphisms (miR-SNPs) in miRNA-processing machinery genes can affect cancer risk, treatment efficacy, and patients’ prognosis by mediating the expression of ...
7
A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma
... for non-Hodgkin’s lymphoma (diffuse large B-cell lymphoma) of the anter- ior chest wall and para-aortic lymph nodes, disease re- currences occurred in the liver and ...
6
Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma
... or Hodgkin lymphoma (HL) is characterized by multinuclear Reed-Sternberg cells (RS cells) ...(12). Non-Hodgkin’s lymphoma (NHL) is a lymph- oproliferative disorder which comprises different hematologic ...
6
Psoriasis vulgaris and familial cancer risk- a population-based study
... of non-melanoma skin cancer among psor- iasis patients ...and non-Hodgkin's lymphoma ...and non-Hodgkin’s lymph- omas, squamous skin cancer and laryngeal cancers; the risk for other malignancies ...
7
Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy
... Abstract: Non-Hodgkin’s lymphoma (NHL) represents a heterogeneous group of malignancies with high diversity in terms of biology, clinical responses, and ...
9
New antibody approaches to lymphoma therapy
... NHL: Non Hodgkin ’ s lymphoma; ADCC: Antibody dependent cellular cytotoxicity; ADC: Antibody drug conjugates; RIT: Radioimmunotherapy; CaRs: Chimeric antigen receptors; BiTEs: Bispecific t-cell ...
12
Fundamentals of the Management of Non Hodgkin Lymphoma
... The incidence of Non-Hodgkin’s lymphomas (NHL) is rising worldwide and if not adequately treated carries a high mortality rate. The pattern and frequency of NHL vary in different populations and geographical ...
8
Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
... In conclusion, this study described high prevalence of HHV-6 A among the patients with Hodgkin and non-Hodgkin’s lymphoma. HHV-6 is related to im- munosuppressive therapy or transfusion of blood and blood ...
6
Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures
... to non-specific clinical manifestations, the disease can be misdiagnosed as other disorders, such as tumors ...(e.g. Non-Hodgkin’s lymphoma) or infectious dis- eases ...
5
Lymphomas of the Head and Neck: CT Findings at Initial Presentation
... TABLE 4: Extranodal Sites of Head and Neck Lymphomas Type of Lymphoma: Site Hodgkin 's disease: Waldeyer's ring: Nasopharynx Tonsil Multiple sites Subtotal Total Non-Hodgkin 's lymphoma:[r] ...
7
Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node
... Surprisingly, we found significantly different expres- sion of NAIP between the RLH lymph nodes and the same number normal lymph nodes in the control group. Considering our finding and taking into account the fact that ...
9
<p>Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma</p>
... All continuous variables were expressed as mean ± SD and categorical variables were expressed as percentages. Normally distributed variables were presented as mean ± SD and compared using independent samples t -test. ...
10
Cancer risk after renal transplantation in South Korea: a nationwide population-based study
... Results: A total of 1343 RTRs (871 males and 472 females, mean age 48.5 ± 11.6 years) were assessed. Among them, 104 (7.7%) developed malignancies after transplantation, most commonly in the thyroid cancer (23.1%). The ...
6
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non Hodgkin and Hodgkin lymphomas
... of non-Hodgkin and Hodgkin lymphoma cell lines, including 2/6 diffuse large B-cell (DLBCL), 1/2 peripheral T cell lymphomas, 5/5 Burkitt, 6/7 Hodgkin and 2/3 nasal killer (NK)/T-cell lymphoma ...
7
<p>Clinical application of obinutuzumab for treating chronic lymphocytic leukemia</p>
... The af fi nity of the antibody for the FcyRIII fragment is very important, which is in fl uenced by the structure of the oligosaccharide attached to the speci fi c Fc fragment in the antibody. A decent af fi nity is needed ...
11